Brägelmann J, et al. Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma. Cell Rep 2017 Sep 19;20(12):2833-2845. doi:10.1016/j.celrep.2017.08.082
